Troponin I elevation after elective percutaneous coronary interventions: Prevalence and risk factors

Troponin elevation after coronary angioplasty is a prognostic marker associated with significant morbidity and mortality, although its prevalence varies according to clinical and procedural characteristics. We analyzed the frequency of post-procedural enzyme elevation among 112 elective intervention...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Roberto Muniz, de Souza e Silva, Nelson Albuquerque, Salis, Lúcia Helena Alvares, Maia, Paula Dias, Horta, Lucas Felipe Bastos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485429/
https://www.ncbi.nlm.nih.gov/pubmed/28648422
http://dx.doi.org/10.1016/j.ihj.2016.11.319
Descripción
Sumario:Troponin elevation after coronary angioplasty is a prognostic marker associated with significant morbidity and mortality, although its prevalence varies according to clinical and procedural characteristics. We analyzed the frequency of post-procedural enzyme elevation among 112 elective interventions between 2013 and 2014 in a private hospital in Brazil. Troponin increase was observed in 62.5% of the procedures, and was related to age, female sex, low pre-procedural hemoglobin, prior angiotensin converting enzyme inhibitor or angiotensin receptor blocker use and multivessel angioplasty. PCI is not a risk free procedure and these results underscore the importance of a careful clinical assessment before its utilization.

Ejemplares similares